J F R Robertson


Ontology type: schema:Person     


Person Info

NAME

J F R

SURNAME

Robertson

Publications in SciGraph latest 50 shown

  • 2018-12 Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells in BREAST CANCER RESEARCH
  • 2018-12 Determinants of motivation to quit in smokers screened for the early detection of lung cancer: a qualitative study in BMC PUBLIC HEALTH
  • 2018-05 Progression-free survival results in postmenopausal Asian women: subgroup analysis from a phase III randomized trial of fulvestrant 500 mg vs anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON) in BREAST CANCER
  • 2017-12 Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial in BMC CANCER
  • 2016-12 Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas in BREAST CANCER RESEARCH
  • 2015-12 A poetic story: lessons learnt from the world's largest breast cancer window of opportunity study in TRIALS
  • 2013-04 A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer in BREAST CANCER RESEARCH
  • 2012-12 Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference in BREAST CANCER RESEARCH AND TREATMENT
  • 2012-11 Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized ‘FIRST’ study in BREAST CANCER RESEARCH AND TREATMENT
  • 2012-10 EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays in TUMOR BIOLOGY
  • 2011-12 Clinical relevance of "withdrawal therapy" as a form of hormonal manipulation for breast cancer in WORLD JOURNAL OF SURGICAL ONCOLOGY
  • 2011-10 Identifying Gaps in the Locoregional Management of Early Breast Cancer: Highlights from the Kyoto Consensus Conference in ANNALS OF SURGICAL ONCOLOGY
  • 2011-10 erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines in BREAST CANCER RESEARCH
  • 2010-12 Session 6 introduction in BREAST CANCER RESEARCH
  • 2010-12 Bony metastases from breast cancer - a study of foetal antigen 2 as a blood tumour marker in WORLD JOURNAL OF SURGICAL ONCOLOGY
  • 2009-12 Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors in BREAST CANCER RESEARCH
  • 2008-01 The impact of delay in cryo-fixation on biomarkers of Src tyrosine kinase activity in human breast and bladder cancers in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2007-12 Successful management of elderly breast cancer patients treated without radiotherapy in WORLD JOURNAL OF SURGICAL ONCOLOGY
  • 2007-12 Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients in BREAST CANCER RESEARCH
  • 2007-08 Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells in BREAST CANCER RESEARCH
  • 2007-07 The Emerging Role of the LIV-1 Subfamily of Zinc Transporters in Breast Cancer in MOLECULAR MEDICINE
  • 2007-01 Fulvestrant in Advanced Male Breast Cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2006-12 "Resurrection of clinical efficacy" after resistance to endocrine therapy in metastatic breast cancer in WORLD JOURNAL OF SURGICAL ONCOLOGY
  • 2006-12 Efficacy and tolerability of high dose "ethinylestradiol" in post-menopausal advanced breast cancer patients heavily pre-treated with endocrine agents in WORLD JOURNAL OF SURGICAL ONCOLOGY
  • 2005-10 Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer in MODERN PATHOLOGY
  • 2005-07 Sensitivity to further endocrine therapy is retained following progression on first-line fulvestrant in BREAST CANCER RESEARCH AND TREATMENT
  • 2004-07 Pharmacokinetic Profile of Intramuscular Fulvestrant in Advanced Breast Cancer in CLINICAL PHARMACOKINETICS
  • 2003-12 A Review of the Efficacy of Anastrozole in Postmenopausal Women with Advanced Breast Cancer with Visceral Metastases in BREAST CANCER RESEARCH AND TREATMENT
  • 2003-10 Equivalent single-dose pharmacokinetics of two different dosing methods of prolonged-release fulvestrant ('Faslodex') in postmenopausal women with advanced breast cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2003-05 Postmenopausal Women who Progress on Fulvestrant ('Faslodex') Remain Sensitive to Further Endocrine Therapy in BREAST CANCER RESEARCH AND TREATMENT
  • 2002-10 Current role of endocrine therapy in the management of breast cancer in BREAST CANCER
  • 2002-07 Treatment Options For Postmenopausal Women with Tamoxifen-Resistant Advanced Breast Cancer in AMERICAN JOURNAL OF CANCER
  • 2001-06 The use of blood tumour markers in the monitoring of metastatic breast cancer unassessable for response to systemic therapy in BREAST CANCER RESEARCH AND TREATMENT
  • 2001-01 Selection of Primary Breast Cancer Patients for Adjuvant Endocrine Therapy – is Oestrogen Receptor Alone Adequate? in BREAST CANCER RESEARCH AND TREATMENT
  • 2001-01 Change in Expression of ER, bcl-2 and MIB1 on Primary Tamoxifen and Relation to Response in ER Positive Breast Cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 1999-11 Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 1998-08 EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival in ONCOGENE
  • 1997-09 Predictors of response to second-line endocrine therapy for breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 1996-10 Prognostic significance of serum c-erbB-2 protein in breast cancer patients in BREAST CANCER RESEARCH AND TREATMENT
  • 1996-02 Effects of short-term antiestrogen treatment of primary breast cancer on estrogen receptor mRNA and protein expression and on estrogen-regulated genes in BREAST CANCER RESEARCH AND TREATMENT
  • 1994-01 Epidermal growth factor receptor expression in breast cancer: Association with response to endocrine therapy in BREAST CANCER RESEARCH AND TREATMENT
  • 1992-06 Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growth in BRITISH JOURNAL OF CANCER
  • 1991-12 Failure of CA19-9 to detect asymptomatic colorectal carcinoma in BRITISH JOURNAL OF CANCER
  • 1991-08 The prognostic value of the monoclonal antibody (D5) detected protein, p29, in primary colorectal carcinoma in BRITISH JOURNAL OF CANCER
  • 1989-06 Ki67 immunostaining in primary breast cancer: pathological and clinical associations in BRITISH JOURNAL OF CANCER
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.4563.4", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417893.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240404.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.16753.36", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.21925.3d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.476460.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411443.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418165.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410569.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.419166.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240145.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5600.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415598.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412920.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418152.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.11899.38", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416266.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413619.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.272242.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418119.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.17091.3e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.466123.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4367.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.63368.38", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412917.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.55325.34", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417815.e", 
            "type": "Organization"
          }
        ], 
        "familyName": "Robertson", 
        "givenName": "J F R", 
        "id": "sg:person.07764637207.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07764637207.20"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T13:34", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_1364.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.07764637207.20'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.07764637207.20'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.07764637207.20'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.07764637207.20'


     

    This table displays all metadata directly associated to this object as RDF triples.

    68 TRIPLES      10 PREDICATES      37 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.07764637207.20 schema:affiliation N4e273b0d229946f293837829c2f83577
    2 https://www.grid.ac/institutes/grid.11899.38
    3 https://www.grid.ac/institutes/grid.16753.36
    4 https://www.grid.ac/institutes/grid.17091.3e
    5 https://www.grid.ac/institutes/grid.21925.3d
    6 https://www.grid.ac/institutes/grid.240145.6
    7 https://www.grid.ac/institutes/grid.240404.6
    8 https://www.grid.ac/institutes/grid.272242.3
    9 https://www.grid.ac/institutes/grid.410569.f
    10 https://www.grid.ac/institutes/grid.411443.7
    11 https://www.grid.ac/institutes/grid.412917.8
    12 https://www.grid.ac/institutes/grid.412920.c
    13 https://www.grid.ac/institutes/grid.413619.8
    14 https://www.grid.ac/institutes/grid.415598.4
    15 https://www.grid.ac/institutes/grid.416266.1
    16 https://www.grid.ac/institutes/grid.417815.e
    17 https://www.grid.ac/institutes/grid.417893.0
    18 https://www.grid.ac/institutes/grid.418119.4
    19 https://www.grid.ac/institutes/grid.418152.b
    20 https://www.grid.ac/institutes/grid.418165.f
    21 https://www.grid.ac/institutes/grid.419166.d
    22 https://www.grid.ac/institutes/grid.4367.6
    23 https://www.grid.ac/institutes/grid.466123.4
    24 https://www.grid.ac/institutes/grid.476460.7
    25 https://www.grid.ac/institutes/grid.55325.34
    26 https://www.grid.ac/institutes/grid.5600.3
    27 https://www.grid.ac/institutes/grid.63368.38
    28 schema:familyName Robertson
    29 schema:givenName J F R
    30 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07764637207.20
    31 schema:sdDatePublished 2019-03-07T13:34
    32 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    33 schema:sdPublisher Nf8420dfa6ab64f7d9eac3970efbac7c6
    34 sgo:license sg:explorer/license/
    35 sgo:sdDataset persons
    36 rdf:type schema:Person
    37 N4e273b0d229946f293837829c2f83577 schema:affiliation https://www.grid.ac/institutes/grid.4563.4
    38 sgo:isCurrent true
    39 rdf:type schema:OrganizationRole
    40 Nf8420dfa6ab64f7d9eac3970efbac7c6 schema:name Springer Nature - SN SciGraph project
    41 rdf:type schema:Organization
    42 https://www.grid.ac/institutes/grid.11899.38 schema:Organization
    43 https://www.grid.ac/institutes/grid.16753.36 schema:Organization
    44 https://www.grid.ac/institutes/grid.17091.3e schema:Organization
    45 https://www.grid.ac/institutes/grid.21925.3d schema:Organization
    46 https://www.grid.ac/institutes/grid.240145.6 schema:Organization
    47 https://www.grid.ac/institutes/grid.240404.6 schema:Organization
    48 https://www.grid.ac/institutes/grid.272242.3 schema:Organization
    49 https://www.grid.ac/institutes/grid.410569.f schema:Organization
    50 https://www.grid.ac/institutes/grid.411443.7 schema:Organization
    51 https://www.grid.ac/institutes/grid.412917.8 schema:Organization
    52 https://www.grid.ac/institutes/grid.412920.c schema:Organization
    53 https://www.grid.ac/institutes/grid.413619.8 schema:Organization
    54 https://www.grid.ac/institutes/grid.415598.4 schema:Organization
    55 https://www.grid.ac/institutes/grid.416266.1 schema:Organization
    56 https://www.grid.ac/institutes/grid.417815.e schema:Organization
    57 https://www.grid.ac/institutes/grid.417893.0 schema:Organization
    58 https://www.grid.ac/institutes/grid.418119.4 schema:Organization
    59 https://www.grid.ac/institutes/grid.418152.b schema:Organization
    60 https://www.grid.ac/institutes/grid.418165.f schema:Organization
    61 https://www.grid.ac/institutes/grid.419166.d schema:Organization
    62 https://www.grid.ac/institutes/grid.4367.6 schema:Organization
    63 https://www.grid.ac/institutes/grid.4563.4 schema:Organization
    64 https://www.grid.ac/institutes/grid.466123.4 schema:Organization
    65 https://www.grid.ac/institutes/grid.476460.7 schema:Organization
    66 https://www.grid.ac/institutes/grid.55325.34 schema:Organization
    67 https://www.grid.ac/institutes/grid.5600.3 schema:Organization
    68 https://www.grid.ac/institutes/grid.63368.38 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...